Cargando…
Protection of pancreatic islets from oxidative cell death by a peripherally-active morphinan with increased drug safety
OBJECTIVE: Dextromethorphan (DXM) is a commonly used antitussive medication with positive effects in people with type 2 diabetes mellitus, since it increases glucose tolerance and protects pancreatic islets from cell death. However, its use as an antidiabetic medication is limited due to its central...
Autores principales: | Scholz, Okka, Huß, Elena, Otter, Silke, Herebian, Diran, Hamacher, Anna, Levy, Laura Mariana, Hristeva, Stanimira, Sanz, Miguel, Ajani, Haresh, Puentes, Alfredo Rodriguez, Hoffmann, Torsten, Hogeback, Jens, Unger, Anke, Terheyden, Susanne, Reina do Fundo, Michelle, Dewidar, Bedair, Roden, Michael, Lammert, Eckhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403733/ https://www.ncbi.nlm.nih.gov/pubmed/37451343 http://dx.doi.org/10.1016/j.molmet.2023.101775 |
Ejemplares similares
-
Synthesis of Morphinan Alkaloids in Saccharomyces cerevisiae
por: Fossati, Elena, et al.
Publicado: (2015) -
Metabolic liver disease in diabetes – From mechanisms to clinical trials
por: Dewidar, Bedair, et al.
Publicado: (2020) -
Pancreatic islet protection at the expense of secretory function involves serine-linked mitochondrial one-carbon metabolism
por: Pelligra, Angela, et al.
Publicado: (2023) -
Pancreatic islet protection at the expense of secretory function involves serine-linked mitochondrial one-carbon metabolism
por: Pelligra, Angela, et al.
Publicado: (2023) -
Structural Determinants for the Binding of Morphinan Agonists to the μ-Opioid Receptor
por: Cong, Xiaojing, et al.
Publicado: (2015)